{
    "body": "Could divalent metal transporter 1 deficiency lead to anemia?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/11090085", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25562168", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10751401", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15024413", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20336479", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15736955", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22580996", 
        "http://www.ncbi.nlm.nih.gov/pubmed/27331785", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26294671", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16085548", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26047847"
    ], 
    "ideal_answer": [
        "Yes, divalent metal transporter 1 (DMT1) deficiency could result in anemia, as DMT1 is a major iron transporter required for iron absorption and erythropoiesis. DMT1 deficiency impairs erythroid differentiation and induces apoptosis of erythroid cells."
    ], 
    "exact_answer": "yes", 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:11758", 
        "http://amigo.geneontology.org/amigo/term/GO:0070838", 
        "http://www.disease-ontology.org/api/metadata/DOID:2355", 
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018798", 
        "http://www.disease-ontology.org/api/metadata/DOID:13121", 
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000740"
    ], 
    "type": "yesno", 
    "id": "58bd672d02b8c60953000011", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 169, 
            "text": "The divalent metal transporter 1 (DMT1) is a major iron transporter required for iron absorption and erythropoiesis. Loss of DMT1 function results in microcytic anemia. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/27331785", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 621, 
            "offsetInEndSection": 891, 
            "text": "Dysfunction of human DMT1 is associated with several pathologies such as iron deficiency anemia hemochromatosis, Parkinson's disease and Alzheimer's disease, as well as colorectal cancer and esophageal adenocarcinoma, making DMT1 an attractive target for drug discovery.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26047847", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 17, 
            "offsetInEndSection": 233, 
            "text": "Deficiency of the divalent metal transporter 1 (DMT1) leads to hypochromic microcytic anemia. We have previously shown that DMT1 deficiency impairs erythroid differentiation and induces apoptosis of erythroid cells. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25562168", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1315, 
            "offsetInEndSection": 1516, 
            "text": "We propose that DMT1 deficiency negatively affects metabolism and life span of mature erythrocytes; two other aspects of defective erythropoiesis which contribute to the pathophysiology of the disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25562168", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 217, 
            "text": "Hypochromic microcytic anemia associated with ineffective erythropoiesis caused by recessive mutations in divalent metal transporter 1 (DMT1) can be improved with high-dose erythropoietin supplementation. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22580996", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 363, 
            "text": "Belgrade rats exhibit microcytic, hypochromic anemia and systemic iron deficiency due to a glycine-to-arginine mutation at residue 185 in a metal ion transporter of a divalent metal transporter/divalent cation transporter/solute carrier 11 group A member 2 or 3 (DMT1/DCT1/SLC11A2), a member of the natural-resistance-associated macrophage protein (Nramp) family.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15736955", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 92, 
            "text": "Deficiency of the divalent metal transporter 1 (DMT1) leads to hypochromic microcytic anemia", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25562168", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 362, 
            "text": "Belgrade rats exhibit microcytic, hypochromic anemia and systemic iron deficiency due to a glycine-to-arginine mutation at residue 185 in a metal ion transporter of a divalent metal transporter/divalent cation transporter/solute carrier 11 group A member 2 or 3 (DMT1/DCT1/SLC11A2), a member of the natural-resistance-associated macrophage protein (Nramp) family", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15736955", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 111, 
            "text": "BACKGROUND/AIMS: Deficiency of the divalent metal transporter 1 (DMT1) leads to hypochromic microcytic anemia. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25562168", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 466, 
            "offsetInEndSection": 652, 
            "text": "Microcytic anemia (mk/mk) mice defective in DMT1 and wild-type mice were exposed to either bleomycin or saline via intratracheal instillation and the resultant lung injury was compared. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20336479", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 93, 
            "text": "Deficiency of the divalent metal transporter 1 (DMT1) leads to hypochromic microcytic anemia.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25562168", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 116, 
            "text": "The divalent metal transporter 1 (DMT1) is a major iron transporter required for iron absorption and erythropoiesis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/27331785", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 702, 
            "offsetInEndSection": 819, 
            "text": "This mutation severely impairs the iron transport capability of DMT1, leading to systemic iron deficiency and anemia.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15024413", 
            "endSection": "abstract"
        }
    ]
}